Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice

Molecular and Cellular Neuroscience

Volumn 37, Issue 3, 2008, Pages 579-589

  Christoph, Thomas ^a   Bahrenberg, Gregor ^a   De Vry, Jean ^a   Englberger, Werner ^a   Erdmann, Volker A ^b   Frech, Moritz ^a   Kögel, Babette ^a   Röhl, Thomas ^b   Schiene, Klaus ^a   Schröder, Wolfgang ^a   Seibler, Jost ^c   Kurreck, Jens ^b,d  

^a GRÜNENTHAL GMBH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Artemis Pharmaceuticals GmbH   (Germany)

^d UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; MESSENGER RNA; SHORT HAIRPIN RNA; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 3;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOT PLATE TEST; HYPERSENSITIVITY; HYPOTHERMIA; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RIBONUCLEASE PROTECTION ASSAY; RNA INTERFERENCE; SPINAL GANGLION; SPINAL NERVE; THERMAL STIMULATION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CALCIUM; CAPSAICIN; DITERPENES; GANGLIA, SPINAL; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; MALE; MICE; NEURONS; PAIN MEASUREMENT; PHENOTYPE; PROTEIN BINDING; REACTION TIME; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPINAL CORD; SPINAL CORD INJURIES; TRPV CATION CHANNELS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 39749089798     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.12.006     Document Type: Article

References (58)

1. Arnold H.H., and Braun T. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. Int. J. Dev. Biol. 40 (1996) 345-353
2. Birder L.A., Nakamura Y., Kiss S., Nealen M.L., Barrick S., Kanai A.J., Wang E., Ruiz G., De Groat W.C., Apodaca G., Watkins S., and Caterina M.J. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci. 5 (2002) 856-860
3. Birmingham A., Anderson E.M., Reynolds A., Ilsley-Tyree D., Leake D., Fedorov Y., Baskerville S., Maksimova E., Robinson K., Karpilow J., Marshall W.S., and Khvorova A. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 3 (2006) 199-204
4. Bolcskei K., Helyes Z., Szabo A., Sandor K., Elekes K., Nemeth J., Almasi R., Pinter E., Petho G., and Szolcsanyi J. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 117 (2005) 368-376
5. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
6. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
7. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
8. Christoph T., Grünweller A., Mika J., Schäfer M.K., Wade E.J., Weihe E., Erdmann V.A., Frank R., Gillen C., and Kurreck J. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem. Biophys. Res. Commun. 350 (2006) 238-243
9. Christoph T., Gillen C., Mika J., Grünweller A., Schäfer M.K., Schiene K., Frank R., Jostock R., Bahrenberg G., Weihe E., Erdmann V.A., and Kurreck J. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1. Neurochem. Int. 50 (2007) 281-290
10. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., and Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405 (2000) 183-187
11. De Souza A.T., Dai X., Spencer A.G., Reppen T., Menzie A., Roesch P.L., He Y., Caguyong M.J., Bloomer S., Herweijer H., Wolff J.A., Hagstrom J.E., Lewis D.L., Linsley P.S., and Ulrich R.G. Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice. Nucleic Acids Res. 34 (2006) 4486-4494
12. Dorn G., Patel S., Wotherspoon G., Hemmings-Mieszczak M., Barclay J., Natt F.J., Martin P., Bevan S., Fox A., Ganju P., Wishart W., and Hall J. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32 (2004) e49
13. Drizin I., Gomtsyan A., Bayburt E.K., Schmidt R.G., Zheng G.Z., Perner R.J., DiDomenico S., Koenig J.R., Turner S.C., Jinkerson T.K., Brown B.S., Keddy R.G., McDonald H.A., Honore P., Wismer C.T., Marsh K.C., Wetter J.M., Polakowski J.S., Segreti J.A., Jarvis M.F., Faltynek C.R., and Lee C.H. Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists. Bioorg. Med. Chem. 14 (2006) 4740-4749
14. Eddy N.B., and Leimbach D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107 (1953) 385-393
15. Eggan K., Akutsu H., Loring J., Jackson-Grusby L., Klemm M., Rideout III W.M., Yanagimachi R., and Jaenisch R. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6209-6214
16. Facer P., Casula M.A., Smith G.D., Benham C.D., Chessell I.P., Bountra C., Sinisi M., Birch R., and Anand P. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol. 7 (2007) 11
17. Ganju P., and Hall J. Potential applications of siRNA for pain therapy. Expert Opin. Biol. Ther. 4 (2004) 531-542
18. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., and Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
19. Grünweller A., and Hartmann R.K. RNA interference as a gene-specific approach for molecular medicine. Curr. Med. Chem. 12 (2005) 3143-3161
20. Grünweller A., Wyszko E., Bieber B., Jahnel R., Erdmann V.A., and Kurreck J. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31 (2003) 3185-3193
21. Guo A., Vulchanova L., Wang J., Li X., and Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci. 11 (1999) 946-958
22. Honore P., Wismer C.T., Mikusa J., Zhu C.Z., Zhong C., Gauvin D.M., Gomtsyan A., El Kouhen R., Lee C.H., Marsh K., Sullivan J.P., Faltynek C.R., and Jarvis M.F. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J. Pharmacol. Exp. Ther. 314 (2005) 410-421
23. Hudson L.J., Bevan S., Wotherspoon G., Gentry C., Fox A., and Winter J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci. 13 (2001) 2105-2114
24. Jackson A.L., and Linsley P.S. Noise amidst the silence: off-target effects of siRNAs?. Trends Genet. 20 (2004) 521-524
25. Jhaveri M.D., Elmes S.J., Kendall D.A., and Chapman V. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naive, carrageenan-inflamed and neuropathic rats. Eur. J. Neurosci. 22 (2005) 361-370
26. Kanai Y., Nakazato E., Fujiuchi A., Hara T., and Imai A. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology 49 (2005) 977-984
27. Kasama S., Kawakubo M., Suzuki T., Nishizawa T., Ishida A., and Nakayama J. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Eur. J. Neurosci. 25 (2007) 2956-2963
28. Kelly S., and Chapman V. Spinal administration of capsazepine inhibits noxious evoked responses of dorsal horn neurons in non-inflamed and carrageenan inflamed rats. Brain Res. 935 (2002) 103-108
29. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
30. Kim D.H., and Rossi J.J. Strategies for silencing human disease using RNA interference. Nat. Rev., Genet. 8 (2007) 173-184
31. Liu M., Willmott N.J., Michael G.J., and Priestley J.V. Differential pH and capsaicin responses of Griffonia simplicifolia IB4 (IB4)-positive and IB4-negative small sensory neurons. Neuroscience 127 (2004) 659-672
32. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
33. Luo M.C., Zhang D.Q., Ma S.W., Huang Y.Y., Shuster S.J., Porreca F., and Lai J. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol. Pain 1 (2005) 29
34. Maddison K., and Clarke A.R. New approaches for modelling cancer mechanisms in the mouse. J. Pathol. 205 (2005) 181-193
35. Maione S., Starowicz K., Palazzo E., Rossi F.S., and Di Marzo V. The endocannabionid and endovanilloid systems and their interactions in neuropathic pain. Drug Dev. Res. 67 (2006) 339-354
36. Michael G.J., and Priestley J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci. 19 (1999) 1844-1854
37. Moqrich A., Hwang S.W., Earley T.J., Petrus M.J., Murray A.N., Spencer K.S.R., Andahazy M., Story G.M., and Patapoutian A. Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307 (2005) 1468-1472
38. Olson E.N., Arnold H.H., Rigby P.W., and Wold B.J. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85 (1996) 1-4
39. Ossipov M.H., Bian D., Malan Jr. T.P., Lai J., and Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 79 (1999) 127-133
40. Overhoff M., Wunsche W., and Sczakiel G. Quantitative detection of siRNA and single-stranded oligonucleotides: relationship between uptake and biological activity of siRNA. Nucleic Acids Res. 32 (2004) e170
41. Peier A.M., Reeve A.J., Andersson D.A., Moqrich A., Earley T.J., Hergarden A.C., Story G.M., Colley S., Hogenesch J.B., McIntyre P., Bevan S., and Patapoutian A. A heat-sensitive TRP channel expressed in keratinocytes. Science 296 (2002) 2046-2049
42. Petersen M., and LaMotte R.H. Relationships between capsaicin sensitivity of mammalian sensory neurons, cell size and type of voltage gated Ca-currents. Brain Res. 561 (1991) 20-26
43. Pomonis J.D., Harrison J.E., Mark L., Bristol D.R., Valenzano K.J., and Walker K. N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine-1( 2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 306 (2003) 387-393
44. Rashid M.H., Inoue M., Kondo S., Kawashima T., Bakoshi S., and Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J. Pharmacol. Exp. Ther. 304 (2003) 940-948
45. Röhl T., and Kurreck J. RNA interference in pain research. J. Neurochem. 99 (2006) 371-380
46. Sakurada T., Katsumata K., Tan-No K., Sakurada S., and Kisara K. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 31 (1992) 1279-1285
47. Scroggs R.S., and Fox A.P. Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size. J. Physiol. 445 (1992) 639-658
48. Seibler J., Zevnik B., Kuter-Luks B., Andreas S., Kern H., Hennek T., Rode A., Heimann C., Faust N., Kauselmann G., Schoor M., Jaenisch R., Rajewsky K., Kuhn R., and Schwenk F. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31 (2003) e12
49. Seibler J., Kuter-Luks B., Kern H., Streu S., Plum L., Mauer J., Kuhn R., Bruning J.C., and Schwenk F. Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res. 33 (2005) e67
50. Seibler J., Kleinridders A., Kuter-Luks B., Niehaves S., Bruning J.C., and Schwenk F. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res. 35 (2007) e54
51. Shi Y. Mammalian RNAi for the masses. Trends Genet. 19 (2003) 9-12
52. 3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents. Naunyn Schmiedebergs Arch. Pharmacol. 347 (1993) 84-91
53. Szallasi A., Cortright D.N., Blum C.A., and Eid S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov. 6 (2007) 357-372
54. Tan P.H., Yang L.C., Shih H.C., Lan K.C., and Cheng J.T. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12 (2005) 59-66
55. Tominaga M. Nociception and TRP channels. Handb. Exp. Pharmacol. (2007) 489-505
56. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., and Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21 (1998) 531-543
57. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
58. Zwick M., Davis B.M., Woodbury C.J., Burkett J.N., Koerber H.R., Simpson J.F., and Albers K.M. Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive, neurons in the mouse. J. Neurosci. 22 (2002) 4057-4065